Basecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models

Basecamp Research trains biological foundation models, called EDEN, on a proprietary genomic dataset spanning more than 30 countries. The models are used to design therapeutics, starting with in vivo cell therapies that reprogram a patient's cells inside the body to treat conditions such as cancer and autoimmune disease.